Kontakte:Errol Zhou (Mesye.)
Tel: plis 86-551-65523315
Mobile/WhatsApp: plis 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Imèl:sales@homesunshinepharma.com
Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin
CAS NON: 441798-33-0
Molekile Fomil: C19H22Br2N6O4S
Molekile pwa: 590,28
EINECS NON: 1308068-626-2
MDL NON: MFCD17167076
Pwodwi deskripsyon
Non pwodwi: Macitentan CAS non: 441798-33-0
Synonyms:
5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl) oxyethoxy]-N-(propylsulfamoyl) pyrimidin-4-amwen;
N-[5-(4-Bromophenyl)-6-{2-[(5-bromo-2-pyrimidinyl) oxy] ethoxy} -4-pyrimidinyl]-n'-propylsulfuric diamide;
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl) oxy] ethoxy] -4-pyrimidinyl]-n'-propyl-;
Macitentan;
Actelyon-1;
Opsumit;
Chimik & pwopriyete fizik
Aparans: blan poud
Épreuves: ≥ 99,0%
Dansite: 1.675 g/cm3
Bouyi pwen: 692.4 ° chat 760 mmHg
Flash pwen: 372.5 ° c
Macitentan (non komes Opsumit) se yon endothelin récepteurs antagonis (ERA) ki apwouve pou tretman an nan maladi ateryel tansyon wo (PAH). Lot de epok commercialisés yo kom nan 2014 yo bosentan ak ambrisentan. Macitentan se yon PERYOD doub, sa vle di ke li aji kom yon antagonis de endothelin (ET) récepteurs kalite sub, ETA ak ETB. Sepandan, macitentan gen yon 50-pliye ogmante selectivity pou la ETA subtip konpare ak kalite a ETB. Dwog la resevwa apwobasyon nan men manje nan men administrasyon ak medikaman (FDA) nan 13 oktob 2013.
Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!
Pwodwi anba patant yo ofri pou R & D objektif selman. Sepandan, responsablite final la manti selman avek achte a.
Baj popilè: macitentan cas non: 441798-33-0, manifaktire, founise, faktori, achte, nan Stock